BIO-key International, Inc.
BKYI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.04 | 0.02 | -0.02 |
| FCF Yield | -23.71% | -18.52% | -22.64% | -9.73% |
| EV / EBITDA | -3.09 | -2.35 | -2.87 | -5.60 |
| Quality | ||||
| ROIC | -12.43% | -15.40% | -7.41% | -21.70% |
| Gross Margin | 76.90% | 72.65% | 82.61% | 82.06% |
| Cash Conversion Ratio | 1.16 | 0.75 | 1.13 | 0.37 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.34% | -1.56% | -4.35% | -0.43% |
| Free Cash Flow Growth | -27.52% | -4.95% | -66.46% | 61.10% |
| Safety | ||||
| Net Debt / EBITDA | 2.22 | 2.04 | 3.97 | -1.15 |
| Interest Coverage | 67.72 | -12.66 | -6.68 | -9.99 |
| Efficiency | ||||
| Inventory Turnover | 0.91 | 1.46 | 0.78 | 0.69 |
| Cash Conversion Cycle | -10.01 | -58.45 | -20.69 | -102.13 |